{
    "title": "China's CanSino reports 'positive' interim data from COVID mRNA booster trial",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11603673/Chinas-CanSino-reports-positive-interim-data-COVID-mRNA-booster-trial.html",
    "date": "2023-01-05",
    "keywords": [
        "vaccine",
        "shot",
        "cansino",
        "mrna",
        "booster",
        "china",
        "trial",
        "omicron",
        "group",
        "grover",
        "meg",
        "shen",
        "country",
        "month",
        "cs2034",
        "kong",
        "rate",
        "konglondon",
        "jan",
        "interim",
        "covid19",
        "midstage",
        "outbreak",
        "zero",
        "covid",
        "policy",
        "chinas",
        "technology",
        "drugmaker",
        "filing",
        "hong",
        "stock",
        "exchange",
        "form",
        "pathogen",
        "case",
        "virus",
        "sarscov2",
        "immune",
        "system",
        "response",
        "illness",
        "use",
        "none",
        "variant",
        "circulation",
        "wuhan",
        "strain",
        "ba1",
        "company",
        "world",
        "health",
        "organization",
        "analysis",
        "predominance",
        "approval",
        "april",
        "year",
        "time",
        "august",
        "safety",
        "profile",
        "sys6006",
        "latestage",
        "phase",
        "statement",
        "concern",
        "nation",
        "number",
        "vaccination",
        "government",
        "public",
        "mainland",
        "sinopharm",
        "sinovac",
        "rollout",
        "pfizerbiontech",
        "moderna",
        "reporting",
        "editing",
        "josephine",
        "mason",
        "tomasz",
        "janowski",
        "elaine",
        "hardcastle"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}